Cutera, Inc. Revises Revenue Guidance for the Year Ended December 31, 2022
January 09, 2023 at 08:34 am
Share
Cutera, Inc. revised revenue guidance for the year ended December 31, 2022. The Company expects to report revenue in the range of $252 million to $253 million for full-year 2022, growing 15% to 16% over the prior year on a constant currency basis versus prior guidance of $255 million to $260 million.
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
CUTERA, INC. 
